MAPT and supranuclear palsy, progressive, 1: Microglia activation assessed by using [11C]PK11195 PET was reported to co-localize with tau and can predict disease progression and tau accumulation assessed by [18F]flortaucipir in patients with PSP (Malpetti et al., 2020, 2021).